ATE360096T1 - Reversibel modifizierte thermostabile enzyme für die in vitro-synthese und -amplifizierung von dna - Google Patents

Reversibel modifizierte thermostabile enzyme für die in vitro-synthese und -amplifizierung von dna

Info

Publication number
ATE360096T1
ATE360096T1 AT02026712T AT02026712T ATE360096T1 AT E360096 T1 ATE360096 T1 AT E360096T1 AT 02026712 T AT02026712 T AT 02026712T AT 02026712 T AT02026712 T AT 02026712T AT E360096 T1 ATE360096 T1 AT E360096T1
Authority
AT
Austria
Prior art keywords
modified thermostable
activity
enzyme
thermostable enzyme
amplification
Prior art date
Application number
AT02026712T
Other languages
English (en)
Inventor
Harald Dr Sobek
Michael Greif
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of ATE360096T1 publication Critical patent/ATE360096T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844Nucleic acid amplification reactions
    • C12Q1/6848Nucleic acid amplification reactions characterised by the means for preventing contamination or increasing the specificity or sensitivity of an amplification reaction
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10Transferases (2.)
    • C12N9/12Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1241Nucleotidyltransferases (2.7.7)
    • C12N9/1252DNA-directed DNA polymerase (2.7.7.7), i.e. DNA replicase
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/16Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/22Ribonucleases RNAses, DNAses
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/99Enzyme inactivation by chemical treatment
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844Nucleic acid amplification reactions
    • C12Q1/686Polymerase chain reaction [PCR]
AT02026712T 2001-12-03 2002-11-30 Reversibel modifizierte thermostabile enzyme für die in vitro-synthese und -amplifizierung von dna ATE360096T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01128725 2001-12-03
US10/317,715 US7378262B2 (en) 2001-12-03 2002-12-11 Reversibly modified thermostable enzymes for DNA synthesis and amplification in vitro

Publications (1)

Publication Number Publication Date
ATE360096T1 true ATE360096T1 (de) 2007-05-15

Family

ID=32963733

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02026712T ATE360096T1 (de) 2001-12-03 2002-11-30 Reversibel modifizierte thermostabile enzyme für die in vitro-synthese und -amplifizierung von dna

Country Status (7)

Country Link
US (1) US7378262B2 (de)
EP (1) EP1319719B8 (de)
JP (1) JP3969581B2 (de)
AT (1) ATE360096T1 (de)
CA (1) CA2409775C (de)
DE (1) DE60219579T2 (de)
ES (1) ES2284769T3 (de)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2004203649B2 (en) 2003-08-12 2006-01-12 F. Hoffmann-La Roche Ag Thermostable Taq polymerase fragment
GB0502010D0 (en) * 2005-02-01 2005-03-09 Enigma Diagnostics Ltd Biochemical reagents and their uses
US20070117114A1 (en) * 2005-07-07 2007-05-24 Quanta Biosciences, Inc. Compositions and methods for increasing amplification efficiency
US8962293B2 (en) 2006-10-18 2015-02-24 Roche Molecular Systems, Inc. DNA polymerases and related methods
CN101050453B (zh) * 2007-04-04 2010-06-30 无锡中德美联生物技术有限公司 一种热启动耐高温dna聚合酶及其制备方法
EP2279263B1 (de) 2008-04-30 2013-09-04 Integrated Dna Technologies, Inc. Tests auf rnase-h-basis mit modifizierten rna-monomeren
CA2802304C (en) 2010-06-18 2016-01-12 F.Hoffman-La Roche Ag Dna polymerases with increased 3'-mismatch discrimination
CA2802239C (en) 2010-06-18 2016-08-23 F. Hoffmann-La Roche Ag Dna polymerases with increased 3'-mismatch discrimination
JP5876479B2 (ja) 2010-06-18 2016-03-02 エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft 増大した3’末端ミスマッチ識別を有するdnaポリメラーゼ
US8722378B2 (en) 2010-06-18 2014-05-13 Roche Molecular Systems, Inc. DNA polymerases with increased 3′-mismatch discrimination
AU2011267421B2 (en) 2010-06-18 2014-04-24 F. Hoffmann-La Roche Ag DNA polymerases with increased 3'-mismatch discrimination
EP2582808B1 (de) 2010-06-18 2015-04-22 Roche Diagniostics GmbH Dna polymerasen mit erhöhter unterscheidung von 3' fehlpaarungen
EP2582806B1 (de) 2010-06-18 2015-12-16 Roche Diagnostics GmbH Dna-polymerasen mit erhöhter unterscheidung von 3'-diskrepanz
ES2536252T3 (es) 2010-06-18 2015-05-21 F. Hoffmann-La Roche Ag ADN polimerasas con diferenciación de desapareamientos 3' aumentada
EP3578205A1 (de) 2010-08-06 2019-12-11 ModernaTX, Inc. Pharmazeutische zusammensetzungen enthaltenbearbeitete nukleinsäuren und ihre medizinische verwendung
CA3162352A1 (en) 2010-10-01 2012-04-05 Modernatx, Inc. Modified nucleosides, nucleotides, and nucleic acids, and uses thereof
US8765435B2 (en) 2011-02-15 2014-07-01 Roche Molecular Systems, Inc. DNA polymerases with increased 3′-mismatch discrimination
DE12722942T1 (de) 2011-03-31 2021-09-30 Modernatx, Inc. Freisetzung und formulierung von manipulierten nukleinsäuren
WO2012139748A1 (en) 2011-04-11 2012-10-18 Roche Diagnostics Gmbh Dna polymerases with improved activity
WO2013013822A1 (en) 2011-07-28 2013-01-31 Roche Diagnostics Gmbh Dna polymerases with improved activity
US9464124B2 (en) 2011-09-12 2016-10-11 Moderna Therapeutics, Inc. Engineered nucleic acids and methods of use thereof
PT3682905T (pt) 2011-10-03 2022-04-07 Modernatx Inc Nucleósidos, nucleótidos e ácidos nucleicos modificados e respetivas utilizações
EP2788481B1 (de) 2011-12-08 2018-03-07 Roche Diagnostics GmbH Dna-polymerasen mit verbesserter aktivität
ES2716277T3 (es) 2011-12-08 2019-06-11 Hoffmann La Roche ADN polimerasas con actividad mejorada
ES2569723T3 (es) 2011-12-08 2016-05-12 F. Hoffmann-La Roche Ag Polimerasas de DNA con actividad mejorada
LT2791160T (lt) 2011-12-16 2022-06-10 Modernatx, Inc. Modifikuotos mrnr sudėtys
US9303079B2 (en) 2012-04-02 2016-04-05 Moderna Therapeutics, Inc. Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins
US9572897B2 (en) 2012-04-02 2017-02-21 Modernatx, Inc. Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins
CA2868996A1 (en) 2012-04-02 2013-10-10 Moderna Therapeutics, Inc. Modified polynucleotides for the production of proteins
US9283287B2 (en) 2012-04-02 2016-03-15 Moderna Therapeutics, Inc. Modified polynucleotides for the production of nuclear proteins
PL2922554T3 (pl) 2012-11-26 2022-06-20 Modernatx, Inc. Na zmodyfikowany na końcach
US8980864B2 (en) 2013-03-15 2015-03-17 Moderna Therapeutics, Inc. Compositions and methods of altering cholesterol levels
CA2923029A1 (en) 2013-09-03 2015-03-12 Moderna Therapeutics, Inc. Chimeric polynucleotides
JP2016538829A (ja) 2013-10-03 2016-12-15 モデルナ セラピューティクス インコーポレイテッドModerna Therapeutics,Inc. 低密度リポタンパク質受容体をコードするポリヌクレオチド
AU2015289583A1 (en) 2014-07-16 2017-02-02 Modernatx, Inc. Chimeric polynucleotides
GB201414745D0 (en) 2014-08-19 2014-10-01 Articzymes As Exonucleases
LT3394093T (lt) 2015-12-23 2022-04-25 Modernatx, Inc. Ox40 ligandus koduojančių polinukleotidų naudojimo būdai
WO2017120612A1 (en) 2016-01-10 2017-07-13 Modernatx, Inc. Therapeutic mrnas encoding anti ctla-4 antibodies
JP7246930B2 (ja) 2016-05-18 2023-03-28 モデルナティエックス インコーポレイテッド インターロイキン-12(il12)をコードするポリヌクレオチドおよびその使用
CN109476718B (zh) 2016-05-18 2023-07-04 莫得纳特斯公司 编码免疫调节多肽的mrna的组合及其用途
WO2018231990A2 (en) 2017-06-14 2018-12-20 Modernatx, Inc. Polynucleotides encoding methylmalonyl-coa mutase
CN107312762B (zh) * 2017-06-23 2020-08-11 苏州点晶生物科技有限公司 一种化学修饰ung酶及其修饰方法和应用
JP2022500046A (ja) 2018-09-13 2022-01-04 エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft 改善されたストランド置換能力を有する変異体dnaポリメラーゼ
US20220056498A1 (en) 2019-01-25 2022-02-24 President And Fellows Of Harvard College Compositions and method for synthesizing nucleic acids
CA3161183A1 (en) 2019-12-12 2021-06-17 President And Fellows Of Harvard College Compositions and methods for light-directed biomolecular barcoding
EP4139456A1 (de) 2020-04-22 2023-03-01 President And Fellows Of Harvard College Isothermische verfahren, zusammensetzungen, kits und systeme zum nachweis von nukleinsäuren

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5338671A (en) * 1992-10-07 1994-08-16 Eastman Kodak Company DNA amplification with thermostable DNA polymerase and polymerase inhibiting antibody
US6410277B1 (en) * 1993-02-19 2002-06-25 Takara Shuzo Co., Ltd. DNA polymersases with enhanced length of primer extension
US5436149A (en) * 1993-02-19 1995-07-25 Barnes; Wayne M. Thermostable DNA polymerase with enhanced thermostability and enhanced length and efficiency of primer extension
US5556772A (en) * 1993-12-08 1996-09-17 Stratagene Polymerase compositions and uses thereof
US5512462A (en) * 1994-02-25 1996-04-30 Hoffmann-La Roche Inc. Methods and reagents for the polymerase chain reaction amplification of long DNA sequences
AU5305296A (en) * 1995-03-07 1996-09-23 Biomolecular Assays, Inc. Pressure cycling reactor
CA2176193A1 (en) * 1995-05-22 1996-11-23 John Wesley Backus Methods for polymerase chain reaction preamplification sterilization by exonucleases in the presence of phosphorothioated primers
US5773258A (en) * 1995-08-25 1998-06-30 Roche Molecular Systems, Inc. Nucleic acid amplification using a reversibly inactivated thermostable enzyme
GB9920194D0 (en) * 1999-08-27 1999-10-27 Advanced Biotech Ltd A heat-stable thermostable DNA polymerase for use in nucleic acid amplification
ATE286981T1 (de) * 1999-09-28 2005-01-15 Roche Diagnostics Gmbh Thermostabiles enzym welches die genauigkeit thermostabiler dna polymerasen erhöht - zur verbesserung der nucleinsäuresynthese und in vitro amplifikation
US20030049614A1 (en) * 1999-10-06 2003-03-13 Holly Hurlbut Hogrefe Compositions for dna amplification, synthesis, and mutagenesis

Also Published As

Publication number Publication date
JP3969581B2 (ja) 2007-09-05
CA2409775A1 (en) 2003-06-03
US20040115639A1 (en) 2004-06-17
US7378262B2 (en) 2008-05-27
ES2284769T3 (es) 2007-11-16
EP1319719A1 (de) 2003-06-18
DE60219579T2 (de) 2008-01-03
EP1319719B8 (de) 2008-08-27
EP1319719B1 (de) 2007-04-18
JP2003199592A (ja) 2003-07-15
DE60219579D1 (de) 2007-05-31
CA2409775C (en) 2010-07-13

Similar Documents

Publication Publication Date Title
DE60219579D1 (de) Reversibel modifizierte thermostabile Enzyme für die in vitro-Synthese und -Amplifizierung von DNA
MX9603608A (es) Metodo de amplificacion de acido nucleico.
DE60334985D1 (de) Rna-nachweisenzyme
WO2001023583A3 (en) Thermostable enzyme promoting the fidelity of thermostable dna polymerases- for improvement of nucleic acid synthesis and amplification in vitro
DE60129549D1 (de) Verbesserte nukleinsäure-modifizierende enzyme
EP2272952B8 (de) Thermostabiler oder thermoactiver DNA-polymerase mit abgeschwächter 3'-5' Exonukleaseaktivität
DE50014190D1 (de) Verwendung von phthalazin-derivaten zur behandlung neurodegenerativer krankheiten
DE69431669D1 (de) Enzymatische nukleiksaüre die nicht-nukleotide enthaltet
FI98378B (fi) Uusi, erittäin termostabiili -amylaasi
DE69613856T2 (de) Thermostabile dna polymerase aus thermoanaerobacter thermohydrosulfuricus und davon abgeleitete mutierte enzyme mit entfernter exonukleaseaktivität
DE68925002D1 (de) Verfahren zur Herstellung von optisch-aktiven alpha-substituierten organischen Säuren und Mikroorganismen und Enzyme, die dafür verwendet werden.
BR9813021A (pt) Processo para preparação microbiana de aminoácidos da famìlia do aspartato e/ou glutamato e agente empregável no processo
ATE309336T1 (de) Umkehrbare modifikation von thermostabilen enzymen
EP0822256A3 (de) Modifizierte thermostabile DNA Polymerase und eine DNA Polymerasezusammensetzung zur Amplifikation von Nukleinsäuren
HUP0302364A2 (hu) Új ciklodextrin-glükonatranszferáz, eljárás ennek előállítására, és eljárás ciklodextrin előállítására ezt az enzimet alkalmazva
MX9207449A (es) Inhibidores de la enzima proteolitica derivada de sacarina.
WO2001061015A3 (de) Thermostable chimeric nucleic acid polymerases and uses thereof
NZ515673A (en) Compositions and methods for labeling of nucleic acid molecules
WO2003089606A3 (en) Thermostable dna polymerases and methods of making same
BR9904104A (pt) Método para enzima de formação de sacarìdeo irredutìvel, enzima de liberação de trehalose, e processo para produção de sacarìdeos empregando as enzimas
DK1404862T3 (da) Termostabile proteinaser fra termofile bakterier
PT1196606E (pt) Enzima litica
DE60313784D1 (de) Enon reduktase gen und mikrobielle herstellung von levodion
DE60100199T2 (de) Verfahren zur enzymatischen Hydrolyse von Mischungen aus Isomaltulose und Trehalulose
MD2709G2 (ro) Mediu nutritiv pentru cultivarea submersă a tulpinii de micromicete Rhizopus arrhizus F 67

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1319719

Country of ref document: EP